281 related articles for article (PubMed ID: 15552961)
1. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital].
Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H
Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
3. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Arata S; Tanaka K; Okazaki H; Kondo M; Morimoto M; Saito S; Numata K; Nakamura S; Sekihara H
Hepatogastroenterology; 2001; 48(38):480-5. PubMed ID: 11379338
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Ishii H; Okada S; Nose H; Okusaka T; Nagahama H; Nakayama H; Nakasuka H; Yoshimori M
Hepatogastroenterology; 1996; 43(10):938-43. PubMed ID: 8884317
[TBL] [Abstract][Full Text] [Related]
9. Multimodality management of hepatocellular carcinoma larger than 10 cm.
Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.
Fuke H; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Takaki H; Nakatsuka A; Yamakado K; Takeda K; Takei Y
Aliment Pharmacol Ther; 2008 Jun; 27(12):1253-60. PubMed ID: 18221404
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
[TBL] [Abstract][Full Text] [Related]
14. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.
Jang JW; Choi JY; Bae SH; Yoon SK; Woo HY; Chang UI; Kim CW; Nam SW; Cho SH; Yang JM; Lee CD
Cancer; 2007 Oct; 110(8):1760-7. PubMed ID: 17724708
[TBL] [Abstract][Full Text] [Related]
15. [The effects of preoperative transcatheter arterial chemoembolization (TAE) for the recurrence of hepatocellular carcinoma (HCC) from the viewpoint of consecutive tumor necrosis effect].
Nakanishi K; Une Y; Haneda T; Okubo H; Tomioka N; Shimamura T; Matsushita M; Sato N; Nakajima Y; Uchino J
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1412-4. PubMed ID: 8854766
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
17. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
[TBL] [Abstract][Full Text] [Related]
18. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Lao OB; Weissman J; Perkins JD
Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
[TBL] [Abstract][Full Text] [Related]
19. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
20. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
Horigome H; Nomura T; Saso K; Itoh M
Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]